Angel Group of Companies has stated that it will be vindicated when investigation conducted by the Food and Drugs Authority (FDA) on its Easter Monday Concert is completed.
The FDA last Thursday ordered Angel Group of Companies to recall its product ‘Adonko’ from the market for contravening the Authority’s code on sale and advertisement of alcoholic beverages.
The Authority further slapped a fine of GH¢25,000 on the company following investigations into circumstances that led to the passing out of dozens of youth and minors at the Baba Yara Sports Stadium in Kumasi after the Easter Monday concert.
But the company questioned why the FDA which approved the product would turn around and question its quality and safety mechanism.
Addressing journalists on Monday, the Marketing Manager for the drink, Samuel Yaw Amankwah, however, appealed to the FDA to reconsider its decision to suspend its registration and advertisement license saying it was committed to cooperate with investigations.
“We also assure the FDA of our full commitment and cooperation with the ongoing investigation even though we are certain that the outcome will confirm the contents of the product remains what the FDA approved,” he said.
According to him, while the event was aimed at rewarding loyal clients of Adonko Bitters, it was difficult to determine the ages of the revellers at the gates since those who came appeared to be of age.
He noted that the company with its “unblemished reputation” would not have deliberately offered alcohol to minors.
Mr Amankwah also noted that the company’s manufacturing practices and quality monitoring systems remained as thoroughly examined and approved by the FBA and that the alleged abuse of the product during the event “was completely unconnected to the safety and quality of Adonko Bitters.”